同时服用埃法维伦兹和异化的药理动力学,药理遗传学和毒性
Jessica Taylor1, Gary Maartens1, Simiso Sokhela2
1Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Southern African journal of HIV medicine
|April 4, 2025
概括
服用 efavirenz 和 isoniazid 的 CYP2B6 缓慢代谢者经历了更高的药物水平和增加的 HDL 胆固醇. 这种CYP2B6基因型没有影响肝酶,葡萄糖或精神症状.
科学领域:
- 药物基因组学 药物基因组学
- 艾滋病毒治疗 艾滋病毒治疗
- 药物新陈代谢 药物新陈代谢
背景情况:
- CYP2B6基因型会影响埃法维伦兹的新陈代谢.
- 伊索尼亚兹可以抑制埃法维伦兹的代谢途径,可能增加药物度.
研究的目的:
- 为了研究 CYP2B6 基因型与艾滋病毒感染者 (PLWH) 接受异化和艾滋病毒感染者中 efavirenz 毒性的关联.
- 探索 CYP2B6 基因型对 efavirenz 度和临床结果的影响.
主要方法:
- 接受异酸和埃法维伦兹的ADVANCE试验 (NCT03122262) 的参与者被基因定型为CYP2B6.6.
- 根据CYP2B6基因型分层,对伊法维伦兹度进行了比较,包括和不含异化.
- 在24周内,分析了CYP2B6基因型,efavirenz度和脂质,ALT,FPG,睡眠和MMS分数的变化之间的关联.
主要成果:
- 与广泛代谢者相比,CYP2B6缓慢代谢者在服用异化物时的埃法维伦兹度更高.
- 更高的埃法维伦兹度与增加的总胆固醇和HDL胆固醇有关.
- 缓慢代谢CYP2B6的患者显示总和HDL胆固醇的增加更大.
结论:
- 服用异酸和埃法维伦兹的CYP2B6缓慢代谢者表现出高的埃法维伦兹度和增加的总和高脂胆固醇.
- 在CYP2B6基因型或efavirenz度与ALT,FPG,LDL胆固醇,甘油三,睡眠质量或MMS得分的变化之间没有发现显著的关联.
相关概念视频
Factors Affecting Drug Response: Overview
1.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.7K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
138
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
138
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
52
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
52
Factors Affecting Drug Biotransformation: Biological
85
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
85
Drug Concentration Versus Time Correlation
544
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
544
Pharmacokinetics: Overview
5.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
5.2K


